EYOWN also offers the client a final assessment table where potential candidates appear and the different processes or parameters evaluated, allowing our clients to make their final decision based on this assessment table.
At EYOWN we understand that in order to offer an efficient advisory service to our clients we have to keep ourselves updated on the new instruments, systems or applications that may arise in the different markets. For this, EYOWN has the following sources of information:
INTERNATIONAL CONSULTING IN FARMA
The objective of EYOWN was to facilitate the generation and implementation of Pharma Clusters throughout the cooperation among all the actors of the public and private health institutions. The aim was to foster the competitive development of regional Pharma companies within the global social and administrative contexts, with special focus on education and research of excellence in the field of human health and innovation.
STRATEGIC PLAN SOUTH KAZAKHSTAN PHARMA CLUSTER
EYOWN global vision consider the public and private researchers and health institutions as an essential part that must favor the discovery, development and commercialization of innovative pharmaceutical products.
EYOWN scientific advisor involved coordination between public and private actors involved in human Health, including universities, Biopharma companies and biotechnology sectors.
EYOWN is compromised to address the real social needs in the human health field. The core activities should be oriented within the strategy of the active integration of the different local and international stakeholders incorporating the vision of the associations of patients in all aspects of ethics and legal constrains, thus favoring alternative opinions in research, clinics and administrative processes.
EYOWN provides support to prioritize strategy for the governance and/or advisory bodies, assuming their compromise in the continuous improvement of the quality of treatments and in the standards of the clinical environment.
EYOWN create strategic tools to educate the human capital (universities, industry, administrative bodies), to promote the research of excellence to design and develop innovative medicine products and, the incorporation of increasing number of innovative drugs in the earliest phases of clinical trials (hospitals, regulatory bodies), the public purchase (Public Sector), and the applied research and medicines production and commercialization according with the strict international standards (companies).
EYOWN favors networking in the international landscape including the continuous bench-marking of the health needs of patients fostering the transnational visibility and internationalization of the partners and clusters, specially in the short-medium term of the European Union markets.
Short-term priority of the Cluster is to implement educational tools that serve to train the young human capital adjusted to the present and future needs of the academic and Pharma companies and the research international community, in order to expand their competitiveness to the private sector at national level and enabling the incorporation of new generations in the overall scientific community in Kazakhstan and abroad.